Martin Petro Joins Tower MSA Partners

Martin Petro Petro delivers more than 20 years’ experience in business administration, utilization review, case management, and pharmaceutical management to the fast-growing Medicare secondary compliance and MSA company. “Martin’s clinical proficiency and business acumen, along with his MSA background, position him to run with our business model,” said Tower CEO Rita Wilson. Most recently Petro was general [...] Continue reading →

FDA Approves Generic Release of Abilify

The U.S. Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. The agency approved generics from Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals. At least one manufacturer, Teva, announced the launch of [...] Continue reading →

The DEA Finally Decides To Reschedule Hydrocodone

Hydrocodone Rescheduled Last week the DEA released a final rule on the rescheduling of hydrocodone removing it from the schedule III controlled substances list in favor of a schedule II designation. To be clear, this decision specifically addresses hydrocodone combination products (i.e., hydrocodone-acetaminophen formulations such as Vicodin) as hydrocodone by itself has always been a schedule II [...] Continue reading →

New Additions to Tower Executive Team

In our continued commitment  to build a unique MSP compliance model focused on  identification, intervention and involvement to stage claims prior to MSA and settlement, I am pleased to announce the addition of two key individuals to the Tower MSA Partners executive team. Scott E. Yasko, MBA Scott joined tower in July to serve as EVP, [...] Continue reading →

Dangers of Tramadol Recognized

On the Job Recently, the DEA made the decision to reclassify Tramadol as a schedule IV controlled substance and the decision will officially go into effect on August 18th. Tramadol is an opioid analgesic and aside from its generic form it can also be found in brand names such as Ultram, ConZip and Ryzolt. This is considerably important news for [...] Continue reading →

Chronic Pain Can Be Managed With Alternative Therapies

alternative therapy Traumatic injuries and opioid therapy can alter the pain pathways in the central nervous system, and this process is called neuroremodeling. This can cause unwanted or undesirable reactions to pain and negatively impact the recovery process. There are several approaches to reversing the neuroremodeling, some of these alternative treatments include cognitive behavior therapy and opioid [...] Continue reading →
Page 1 of 7123456»...Last »